Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in North America and Europe, with increasing prevalence in other regions of the world. Its spectrum encompass steatosis, non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis. It is considered as the manifestation of metabolic syndrome in liver, and its development and progression is influenced by complex interaction of environmental and genetic factors. In this review we discuss the histopathological features, differential diagnoses, and the commonly used grading and staging systems of NAFLD. NAFLD associated with other diseases, histological changes after therapeutic intervention and recurrence or occurrence of NAFLD after liver transplantation are also addressed.
| Original language | English |
|---|---|
| Pages (from-to) | 68-77 |
| Number of pages | 10 |
| Journal | Journal of the Formosan Medical Association |
| Volume | 120 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2021 |
| Externally published | Yes |
Keywords
- Fatty liver
- Nonalcoholic fatty liver disease
- Nonalcoholic steatohepatitis
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Non-alcoholic fatty liver disease: A review with clinical and pathological correlation'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS